Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has results × Sarcoidosis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1580 Neoplasms 1149 Carcinoma, Non-Small-Cell Lung 1063 Prostatic Neoplasms 868 Multiple Myeloma 690 Leukemia, Myeloid, Acute 628 Neoplasm Metastasis 585 Lung Neoplasms 555 Colorectal Neoplasms 553 Melanoma 544 Lymphoma 524 Leukemia 481 Lymphoma, Non-Hodgkin 466 Leukemia, Lymphocytic, Chronic, B-Cell 432 Ovarian Neoplasms 430 Pancreatic Neoplasms 411 Precursor Cell Lymphoblastic Leukemia-Lymphoma 389 Recurrence 378 Myelodysplastic Syndromes 342 Lymphoma, Follicular 330 Head and Neck Neoplasms 319 Brain Neoplasms 314 Carcinoma, Renal Cell 312 Glioblastoma 311 Lymphoma, Large B-Cell, Diffuse 300 Hodgkin Disease 276 Carcinoma, Hepatocellular 271 Squamous Cell Carcinoma of Head and Neck 254 Lymphoma, Mantle-Cell 246 Urinary Bladder Neoplasms 222

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00311246 2020-08-25

Trial of Adalimumab in Progressive Sarcoidosis

University of Chicago

Phase 2 Terminated

11 enrolled 8 charts

Sarcoidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡